Errors in cancer research can lead to incorrect or suboptimal treatment plans. For instance, an error in genomic sequencing might misidentify a mutation, leading to the prescription of an ineffective targeted therapy. Similarly, errors in clinical trial data can affect the approval of new drugs, delaying access to potentially life-saving treatments.
